Medidata Solutions Further Extends Support for Industry Standards with Medidata Standards Accelerator
Medidata Solutions announced its latest services offering, Medidata Standards AcceleratorTM, which provides end-to-end support for the Clinical Data Interchange Standards Consortium (CDISC) study data tabulation model (SDTM)–the FDA’s recommended format for electronic submission of case report form data. With this offering, Medidata enables sponsors to satisfy FDA submission guidelines in a repeatable fashion, while reducing time and costs.
Medidata’s services team works with sponsors using the Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) platform throughout the study lifecycle to streamline the preparation of SDTM-ready data and the export of SDTM-compliant datasets. In addition to the best practices utilized by Medidata services professionals, Standards Accelerator includes multiple tools aimed at streamlining the preparation of SDTM-compliant data sets:
- Pre-built CDASH forms for 17 standard SDTM domains;
- Rave dictionaries using CDISC-controlled terminology;
- Edit checks for SDTM validation rules to minimize data errors.
A longtime CDISC Corporate Sponsor and Registered Solution Provider, Medidata has had a number of its executives formally recognized by CDISC for their individual contributions to standard definitions and ongoing participation in standard groups. Additionally, Rave was the first to be software product certified on all eight Operational Data Model (ODM) use-cases for full interoperability and sharing of clinical data. Rave also was the first EDC solution to provide clinical data acquisition standards harmonization (CDASH) metadata. Medidata Designer®, a study protocol and design solution, has contributed its model to CDISC’s protocol representation model.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
